查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1279668

2022-2029年全球人工智慧在糖尿病管理中的市場規模研究和預測，按類型、按應用和區域分析

Global Artificial Intelligence in Diabetes Management Market Size study & Forecast, by Type, by Application and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

糖尿病管理中的人工智慧（AI）是指使用先進的計算技術，如機器學習演算法，來協助糖尿病的管理和治療。人工智慧在糖尿病管理中的目標是説明患者更有效地監測和管理血糖水準，降低併發症的風險，並提高他們的整體生活品質。全球糖尿病管理市場中人工智慧（AI）的主要驅動因素是糖尿病的患病率增加，AI和機器學習的進步以及對個人化醫療保健的需求增加。此外，可穿戴設備的日益普及以及人工智慧和機器學習的不斷進步正在為市場在 2022-2029 年的預測期內創造有利可圖的增長機會。

在非洲，國際糖尿病聯合會（IDF）估計，2019年有1940萬糖尿病患者，預計到2045年，這一數位將上升到4700萬。 (來源：IDF糖尿病地圖，第9版，2019年）。同樣，在東南亞，IDF估計2019年有8800萬糖尿病患者，到2045年這一數位預計將上升到1.53億。 (資料來源：IDF糖尿病地圖，第九版，2019年）。與此同時，在西太平洋地區，IDF估計2019年有1.59億糖尿病患者，到2045年這一數位預計將上升到2.14億。 (資料來源：IDF糖尿病地圖，第九版，2019年）。然而，在2022-2029年的整個預測期間，糖尿病管理中的人工智慧（AI）的高成本扼殺了市場增長。

全球糖尿病管理中的人工智慧（AI）市場研究涵蓋的主要地區包括亞太、北美、歐洲、拉美和世界其他地區。北美市場是糖尿病管理中人工智慧的最大市場，主要是受該地區糖尿病的高發病率、先進的醫療基礎設施的可用性以及數位技術的採用所驅動。美國是北美最大的市場，其次是加拿大。亞太地區的糖尿病管理人工智慧市場預計將大幅增長，其驅動因素包括糖尿病的高發病率、醫療支出的增加以及數位技術的日益採用。中國、印度和日本是亞太地區的主要市場。

該研究的目的是定義近年來不同市場區隔和國家的市場規模，並預測未來幾年的價值。該報告旨在涵蓋參與研究的國家/地區的該行業的定性和定量方面。

該報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來增長。此外，它還涵蓋了微觀市場的潛在機會，供利益相關者投資，並詳細分析了競爭格局和主要參與者的產品。 .

目錄

第一章：執行摘要

  • 市場簡介
  • 2019-2029年全球和細分市場的估計和預測
    • 糖尿病管理中的人工智慧（AI）市場，按地區分類，2019-2029年
    • 糖尿病管理中的人工智慧（AI）市場，按類型分類，2019-2029年
    • 糖尿病管理中的人工智慧（AI）市場，按應用，2019-2029年
  • 主要趨勢
  • 估算方法
  • 研究假設

第二章：全球糖尿病管理中的人工智慧（AI）市場的定義和範圍

  • 本研究的目的
  • 市場定義和範圍
    • 研究的範圍
    • 行業演變
  • 研究涵蓋的年份
  • 貨幣兌換率

第三章：全球糖尿病管理中的人工智慧（AI）市場動態

  • 糖尿病管理中的人工智慧（AI）市場影響分析（2019-2029）。
    • 市場驅動力
      • 糖尿病的發病率不斷上升
      • 人工智慧和機器學習的進步
      • 對個性化醫療的需求不斷增加
    • 市場挑戰
      • 糖尿病管理中的人工智慧（AI）成本高
    • 市場機會
      • 可穿戴設備的採用越來越多
      • 人工智慧和機器學習的進步

第四章：全球糖尿病管理中的人工智慧（AI）市場行業分析

  • 波特的5力模型
    • 供應商的議價能力
    • 買方的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭性的競爭
  • 波特五力模型的未來方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 經濟
    • 社會
    • 技術
  • 投資採用模式
  • 分析師建議和結論
  • 最佳投資機會
  • 最佳策略

第五章：風險評估：COVID-19的影響

  • 評估COVID-19對行業的整體影響
  • COVID-19前和COVID-19後的市場情況

第六章：全球糖尿病管理中的人工智慧（AI）市場，按類型分類

  • 市場簡介
  • 全球糖尿病管理中的人工智慧（AI）市場，按類型、性能- 潛力分析
  • 2019-2029年全球糖尿病管理中的人工智慧（AI）市場按類型估計和預測
  • 糖尿病管理中的人工智慧（AI）市場，分項分析
    • 基於案例的推理
    • 智慧數據分析

第七章：全球糖尿病管理中的人工智慧（AI）市場，按應用分類

  • 市場簡介
  • 全球糖尿病管理中的人工智慧（AI）市場，按應用，性能- 潛力分析
  • 2019-2029年全球糖尿病管理中的人工智慧（AI）市場按應用估計和預測
  • 糖尿病管理中的人工智慧（AI）市場，分項分析
    • 葡萄糖監測設備
    • 診斷設備
    • 胰島素輸送設備
    • 其他設備

第八章：全球糖尿病管理中的人工智慧（AI）市場，區域分析

  • 糖尿病管理中的人工智慧（AI）市場，區域市場簡介
  • 北美洲
    • 美國
      • 類型細分估計和預測，2019-2029年
      • 應用分類估計和預測，2019-2029年
    • 加拿大
  • 歐洲糖尿病管理中的人工智慧（AI）市場簡介
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區糖尿病管理中的人工智慧（AI）市場簡介
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉美糖尿病管理中的人工智慧（AI）市場簡介
    • 巴西
    • 墨西哥
  • 世界其他地區

第九章：競爭情報

  • 頂級市場戰略
  • 公司簡介
    • Abbott Laboratories
      • 關鍵資訊
      • 概況
      • 財務（取決於數據的可用性）
      • 產品摘要
      • 近期發展情況
    • Medtronic
    • Dexcom
    • Glooko
    • Diabeloop
    • Bigfoot Biomedical
    • Beta Bionics
    • One Drop
    • Diabnext
    • Tidepool

第十章：研究過程

  • 研究過程
    • 資料探勘
    • 數據分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Artificial Intelligence (AI) in Diabetes Management Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Artificial Intelligence (AI) in diabetes management refers to the use of advanced computing technologies, such as machine learning algorithms, to assist in the management and treatment of diabetes. The goal of AI in diabetes management is to help patients monitor and manage their blood sugar levels more effectively, reduce the risk of complications, and improve their overall quality of life. The major driving factors for the Global Artificial Intelligence (AI) in Diabetes Management Market are growing prevalence of diabetes, advancements in AI and machine learning and increasing demand for personalized healthcare. Moreover, growing adoption of wearable devices and rising advancements in AI and machine learning is creating lucrative growth opportunity for the market over the forecast period 2022-2029.

In Africa, the International Diabetes Federation (IDF) estimates that there were 19.4 million people with diabetes in 2019, and this number is expected to rise to 47 million by 2045. (Source: IDF Diabetes Atlas, 9th edition, 2019). Similarly, in South-East Asia, the IDF estimates that there were 88 million people with diabetes in 2019, and this number is expected to rise to 153 million by 2045. (Source: IDF Diabetes Atlas, 9th edition, 2019). Along with this, in the Western Pacific region, the IDF estimates that there were 159 million people with diabetes in 2019, and this number is expected to rise to 214 million by 2045. (Source: IDF Diabetes Atlas, 9th edition, 2019). However, the high cost of Artificial Intelligence (AI) in Diabetes Management stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Artificial Intelligence (AI) in Diabetes Management Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. The North American market is the largest market for AI in diabetes management, primarily driven by the high prevalence of diabetes in the region, the availability of advanced healthcare infrastructure, and the adoption of digital technologies. The US is the largest market in North America, followed by Canada. The Asia Pacific market for AI in diabetes management is expected to grow at a significant rate, driven by factors such as the high prevalence of diabetes, increasing healthcare expenditure, and growing adoption of digital technologies. China, India, and Japan are the major markets in the Asia Pacific region.

Major market players included in this report are:

  • Abbott Laboratories
  • Medtronic
  • Dexcom
  • Glooko
  • Diabeloop
  • Bigfoot Biomedical
  • Beta Bionics
  • One Drop
  • Diabnext
  • Tidepool

Recent Developments in the Market:

  • In May 2021, Abbott Laboratories announced that it had received FDA clearance for its AI-powered algorithm, which is designed to help people with diabetes better manage their glucose levels using the FreeStyle Libre 2 CGM system.
  • In February 2021, Medtronic announced that it had received CE Mark approval for its AI-powered predictive insulin dosing algorithm, which is designed to help people with diabetes avoid hypoglycemia.
  • In January 2021, Dexcom announced that it had acquired TypeZero Technologies, a company that develops AI-powered diabetes management solutions, to enhance its product offerings in the AI diabetes management space.
  • In December 2020, Glooko announced that it had received FDA clearance for its AI-powered insulin titration solution, which is designed to help healthcare providers adjust insulin doses for people with diabetes more efficiently.

Global Artificial Intelligence (AI) in Diabetes Management Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Application, Type, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Case-based Reasoning
  • Intelligent Data Analysis

By Application:

  • Glucose Monitoring Devices
  • Diagnostic Devices
  • Insulin Delivery Devices
  • Other Devices

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Artificial Intelligence (AI) in Diabetes Management Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Artificial Intelligence (AI) in Diabetes Management Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Artificial Intelligence (AI) in Diabetes Management Market, by Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Artificial Intelligence (AI) in Diabetes Management Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Artificial Intelligence (AI) in Diabetes Management Market Dynamics

  • 3.1. Artificial Intelligence (AI) in Diabetes Management Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of diabetes
      • 3.1.1.2. Advancements in AI and machine learning
      • 3.1.1.3. Increasing demand for personalized healthcare
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of Artificial Intelligence (AI) in Diabetes Management
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing adoption of wearable devices
      • 3.1.3.2. Advancements in AI and machine learning

Chapter 4. Global Artificial Intelligence (AI) in Diabetes Management Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Artificial Intelligence (AI) in Diabetes Management Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Artificial Intelligence (AI) in Diabetes Management Market by Type, Performance - Potential Analysis
  • 6.3. Global Artificial Intelligence (AI) in Diabetes Management Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Artificial Intelligence (AI) in Diabetes Management Market, Sub Segment Analysis
    • 6.4.1. Case-based Reasoning
    • 6.4.2. Intelligent Data Analysis

Chapter 7. Global Artificial Intelligence (AI) in Diabetes Management Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Artificial Intelligence (AI) in Diabetes Management Market by Application, Performance - Potential Analysis
  • 7.3. Global Artificial Intelligence (AI) in Diabetes Management Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Artificial Intelligence (AI) in Diabetes Management Market, Sub Segment Analysis
    • 7.4.1. Glucose Monitoring Devices
    • 7.4.2. Diagnostic Devices
    • 7.4.3. Insulin Delivery Devices
    • 7.4.4. Other Devices

Chapter 8. Global Artificial Intelligence (AI) in Diabetes Management Market, Regional Analysis

  • 8.1. Artificial Intelligence (AI) in Diabetes Management Market, Regional Market Snapshot
  • 8.2. North America Artificial Intelligence (AI) in Diabetes Management Market
    • 8.2.1. U.S. Artificial Intelligence (AI) in Diabetes Management Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Artificial Intelligence (AI) in Diabetes Management Market
  • 8.3. Europe Artificial Intelligence (AI) in Diabetes Management Market Snapshot
    • 8.3.1. U.K. Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.2. Germany Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.3. France Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.4. Spain Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.5. Italy Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.6. Rest of Europe Artificial Intelligence (AI) in Diabetes Management Market
  • 8.4. Asia-Pacific Artificial Intelligence (AI) in Diabetes Management Market Snapshot
    • 8.4.1. China Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.2. India Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.3. Japan Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.4. Australia Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.5. South Korea Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.6. Rest of Asia Pacific Artificial Intelligence (AI) in Diabetes Management Market
  • 8.5. Latin America Artificial Intelligence (AI) in Diabetes Management Market Snapshot
    • 8.5.1. Brazil Artificial Intelligence (AI) in Diabetes Management Market
    • 8.5.2. Mexico Artificial Intelligence (AI) in Diabetes Management Market
  • 8.6. Rest of The World Artificial Intelligence (AI) in Diabetes Management Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Abbott Laboratories
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Medtronic
    • 9.2.3. Dexcom
    • 9.2.4. Glooko
    • 9.2.5. Diabeloop
    • 9.2.6. Bigfoot Biomedical
    • 9.2.7. Beta Bionics
    • 9.2.8. One Drop
    • 9.2.9. Diabnext
    • 9.2.10. Tidepool

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Artificial Intelligence (AI) in Diabetes Management Market, report scope
  • TABLE 2. Global Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Artificial Intelligence (AI) in Diabetes Management Market
  • TABLE 70. List of primary sources, used in the study of global Artificial Intelligence (AI) in Diabetes Management Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Artificial Intelligence (AI) in Diabetes Management Market, research methodology
  • FIG 2. Global Artificial Intelligence (AI) in Diabetes Management Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Artificial Intelligence (AI) in Diabetes Management Market, key trends 2021
  • FIG 5. Global Artificial Intelligence (AI) in Diabetes Management Market, growth prospects 2022-2029
  • FIG 6. Global Artificial Intelligence (AI) in Diabetes Management Market, porters 5 force model
  • FIG 7. Global Artificial Intelligence (AI) in Diabetes Management Market, pest analysis
  • FIG 8. Global Artificial Intelligence (AI) in Diabetes Management Market, value chain analysis
  • FIG 9. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Artificial Intelligence (AI) in Diabetes Management Market, regional snapshot 2019 & 2029
  • FIG 15. North America Artificial Intelligence (AI) in Diabetes Management Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Artificial Intelligence (AI) in Diabetes Management Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Artificial Intelligence (AI) in Diabetes Management Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Artificial Intelligence (AI) in Diabetes Management Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Artificial Intelligence (AI) in Diabetes Management Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable